Single-Dose Pharmacokinetics of BMS-790052 in Participants With Hepatic Impairment

NCT00859053 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
46
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bristol-Myers Squibb